会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 54. 发明专利
    • Use of new or known N-benzyl N-phenyl benzenesulfonamide derivatives to prepare medicaments for treating or preventing viral diseases
    • DE102006013957A1
    • 2007-10-04
    • DE102006013957
    • 2006-03-27
    • BAYER HEALTHCARE AG
    • URBAN ANDREASBROHM DIRKBIRKMANN ALEXANDERSCHOHE-LOOP RUDOLFKOLETZKI DIANAHARRENGA AXELSTOLL FRIEDERIKEMUNDT STEFANPAULSEN DANIELA
    • C07C311/21A61K31/18A61P31/14
    • N-benzyl N-phenyl benzenesulfonamide derivatives (I) are used to prepare medicaments for treating or preventing viral diseases. N-benzyl N-phenyl benzenesulfonamide derivatives of formula (I) or their salts or solvates are used to prepare medicaments for treating or preventing viral diseases. R 1>OH or NR 9>R 10>; R 9>, R 10>H, 1-6C alkyl, or benzyl or 2-phenylethyl optionally substituted with 1-3 of halo, CN, OH, NH 2, CF 3, OCF 3, 1-4C alkyl, 1-4C alkoxy and 1-4C alkylamino; R 2>, R 3>H, halo, CN, OH, NH 2, CF 3 or OCF 3; 1-4C alkyl, 1-4C alkoxy or 1-4C alkylamino optionally substituted with 1-3 of halo, CN, OH, NH 2, CF 3 or OCF 3; or N-bonded 5- to 7-membered heterocyclyl optionally substituted with 1-3 of halo, CN, OH, NH 2, CF 3, OCF 3, 1-4C alkyl, 1-4C alkoxy and 1-4C alkylamino; R 1>+R 2>OCH 2 with O bonded to the CO group; R 4>halo, CN, Me, Et or cyclopropyl; R 5>H; 1-4C alkyl, 2-4C alkenyl, 1-4C alkoxy, 1-4C alkylthio or 1-4C alkylamino, all optionally substituted with a phenyl or 5- to 10-membered heteroaryl group optionally substituted with 1-3 of halo, CN, OH, NH 2, CF 3, OCF 3, CONH 2, SO 2NH 2, 1-4C alkyl, 1-4C alkoxy and 1-4C alkylamino; or CH 2YR 12>; Y : O, S or NR 12>; R 12>H, 1-4C alkyl or 3-6C cycloalkyl; R 11>5- to 10-membered heteroaryl optionally substituted with 1-3 of halo, CN, OH, NH 2, CF 3, OCF 3, CONH 2, SO 2NH 2, 1-4C alkyl, 1-4C alkoxy and 1-4C alkylamino; R 6>halo, CN, NO 2, Me, Et, CF 3, OCF 3 or 2-cyanovinyl; R 7>H; or 1-4C alkyl, 2-4C alkenyl, 1-4C alkoxy, 1-4C alkylthio or 1-4C alkylamino, all optionally substituted with a phenyl or 5- to 10-membered heteroaryl group optionally substituted with 1-3 of halo, CN, OH, NH 2, CF 3, OCF 3, CONH 2, SO 2NH 2, 1-4C alkyl, 1-4C alkoxy and 1-4C alkylamino; R 8>halo, CN, NO 2, Me, Et, CF 3 or OCF 3. Independent claims are also included for: (1) new compounds (I) with the definitions given below; (2) a process for preparing (I). R 1>OH or NR 9>R 10>; R 9>, R 10>H, or 1-6C alkyl; R 2>, R 3>H, halo, CN, OH, NH 2, CF 3, OCF 3, 1-4C alkyl, 1-4C alkoxy, 1-4C alkylamino or N-bonded 5- to 7-membered heterocyclyl; R 1>+R 2>OCH 2 with O bonded to the CO group; R 3>H; R 4>halo, CN, Me, Et or cyclopropyl; R 5>H; R 6>halo, CN, NO 2, Me, Et, CF 3, OCF 3 or 2-cyanovinyl; R 7>H; R 8>halo, CN, NO 2, Me, Et, CF 3 or OCF 3. [Image] ACTIVITY : Virucide; Hepatotropic; Antiinflammatory. MECHANISM OF ACTION : Hepatitis C virus RNA replication inhibitor. Test details are described but no results given.